KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLong-Term Debt IssuancesLong-Term Debt RepaymentsR&D In ProcessShares RepurchasedShort-Term Debt issuances
Ratios

Eli Lilly (LLY) Other Gross PP&E Adjustments (2016 - 2019)

Historic Other Gross PP&E Adjustments for Eli Lilly (LLY) over the last 10 years, with Q4 2019 value amounting to -$532.1 million.

  • Eli Lilly's Other Gross PP&E Adjustments changed N/A to -$532.1 million in Q4 2019 from the same period last year, while for Dec 2019 it was -$532.1 million, marking a year-over-year change of. This contributed to the annual value of -$532.1 million for FY2019, which is N/A changed from last year.
  • Per Eli Lilly's latest filing, its Other Gross PP&E Adjustments stood at -$532.1 million for Q4 2019.
  • In the past 5 years, Eli Lilly's Other Gross PP&E Adjustments registered a high of $17.7 billion during Q3 2017, and its lowest value of -$546.5 million during Q1 2019.
  • Its 4-year average for Other Gross PP&E Adjustments is $11.6 billion, with a median of $16.6 billion in 2015.
  • Its Other Gross PP&E Adjustments has fluctuated over the past 5 years, first skyrocketed by 180.34% in 2015, then soared by 377.03% in 2016.
  • Eli Lilly's Other Gross PP&E Adjustments (Quarter) stood at $16.6 billion in 2015, then rose by 3.77% to $17.2 billion in 2016, then rose by 2.86% to $17.7 billion in 2017, then tumbled by 103.0% to -$532.1 million in 2019.
  • Its last three reported values are -$532.1 million in Q4 2019, -$535.7 million for Q3 2019, and -$545.5 million during Q2 2019.